Lv5
1002 积分 2025-09-18 加入
Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse
2个月前
已关闭
Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation
2个月前
已完结
A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease
2个月前
已完结
The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses
3个月前
已完结
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
4个月前
已完结
The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis
4个月前
已完结
Liraglutide Attenuates Hepatic Ischemia–Reperfusion Injury by Modulating Macrophage Polarization
4个月前
已完结
Liraglutide and GLP-1(9–37) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3β/Nrf2 pathway and SMAD159/Hepcidin/FTH pathway
4个月前
已完结
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial
4个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
4个月前
已完结
皖公网安备34019202002308
